BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37059730)

  • 1. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway.
    Mao XG; Xue XY; Lv R; Ji A; Shi TY; Chen XY; Jiang XF; Zhang X
    Cell Death Dis; 2023 Apr; 14(4):269. PubMed ID: 37059730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
    Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
    Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
    Li L; Huang Y; Gao Y; Shi T; Xu Y; Li H; Hyytiäinen M; Keski-Oja J; Jiang Q; Hu Y; Du Z
    BMC Cancer; 2018 Dec; 18(1):1215. PubMed ID: 30514230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
    Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
    Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
    Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
    Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
    Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia Regulated Gene Network in Glioblastoma Has Special Algebraic Topology Structures and Revealed Communications Involving Warburg Effect and Immune Regulation.
    Mao XG; Xue XY; Wang L; Wang L; Li L; Zhang X
    Cell Mol Neurobiol; 2019 Nov; 39(8):1093-1114. PubMed ID: 31203532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
    J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.
    Tsai YT; Wu AC; Yang WB; Kao TJ; Chuang JY; Chang WC; Hsu TI
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
    Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
    Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
    Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways.
    Nicolas S; Abdellatef S; Haddad MA; Fakhoury I; El-Sibai M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31698752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
    Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
    J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.
    Binder ZA; Thorne AH; Bakas S; Wileyto EP; Bilello M; Akbari H; Rathore S; Ha SM; Zhang L; Ferguson CJ; Dahiya S; Bi WL; Reardon DA; Idbaih A; Felsberg J; Hentschel B; Weller M; Bagley SJ; Morrissette JJD; Nasrallah MP; Ma J; Zanca C; Scott AM; Orellana L; Davatzikos C; Furnari FB; O'Rourke DM
    Cancer Cell; 2018 Jul; 34(1):163-177.e7. PubMed ID: 29990498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.